Search

Your search keyword '"Kelly, Elizabeth A."' showing total 2,047 results

Search Constraints

Start Over You searched for: Author "Kelly, Elizabeth A." Remove constraint Author: "Kelly, Elizabeth A."
2,047 results on '"Kelly, Elizabeth A."'

Search Results

202. Data from Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy

208. Proposal for a Hagan Container Surveillance Plan

211. SAVY-4000 Corrosion Evaluation Plan

212. Regional comparison of self-reported late pregnancy cigarette smoking to mass spectrometry analysis

213. HIV vaccines induce CD8+ T cells with low antigen receptor sensitivity.

214. Influence of social determinants of health on breastfeeding intent in the United States.

216. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

218. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated

219. AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

222. CD8+ T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types

223. D-CRAFT Project Update

224. sj-docx-1-tec-10.1177_02711214231182023 – Supplemental material for Families’ Experiences With Online Instruction and Behavior Support During COVID-19

225. Additional file 1 of Coding long COVID: characterizing a new disease through an ICD-10 lens

226. Covert attention in audiovisual speech perception

227. Discoverability beyond the library: Wikipedia

230. Bias in Automatic Speech Recognition: The Case of African American Language

233. 1110. AZD7442 (Tixagevimab/Cilgavimab) Demonstrates Potent In Vitro Activity Against SARS-CoV-2 Spike Variants Identified in Circulation and in Prophylaxis Clinical Studies

234. 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults

235. 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination

236. School and learning contexts during the COVID-19 pandemic: Implications for child and youth mental health

238. Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring

244. Gamification in Science Education: The Relationship of Educational Games to Motivation and Achievement

247. Evaluating Corrosion Effects on the Stainless Steel Components of the SAVY-4000/Hagan Nuclear Material Storage Containers: FY19 Update

Catalog

Books, media, physical & digital resources